Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
2
20%
Ph phase_3
1
10%
Ph phase_4
6
60%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
6(60.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(9)
Other(1)

Detailed Status

Completed9
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 31 (10.0%)
Phase 46 (60.0%)
N/A2 (20.0%)

Trials by Status

unknown110%
completed990%

Recent Activity

0 active trials
Showing 5 of 10
unknownnot_applicable

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

NCT05101005
completedphase_4

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

NCT01502904
completedphase_4

Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

NCT01035450
completednot_applicable

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

NCT01887704
completedphase_4

Focal In-stent Restenosis After Drug-Eluting Stent

NCT00485004
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05101005Not Applicable

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Unknown
NCT01502904Phase 4

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Completed
NCT01035450Phase 4

Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

Completed
NCT01887704Not Applicable

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

Completed
NCT00485004Phase 4

Focal In-stent Restenosis After Drug-Eluting Stent

Completed
NCT00611910Phase 4

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions

Completed
NCT00133237Phase 4

Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

Completed
NCT00263263Phase 2

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

Completed
NCT00258596Phase 3

Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions

Completed
NCT00297661Phase 4

Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

Completed

All 10 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
10